See more : Klegg Electronics, Inc. (KLGG) Income Statement Analysis – Financial Results
Complete financial analysis of DENTSPLY SIRONA Inc. (XRAY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DENTSPLY SIRONA Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Choice International Limited (CHOICEIN.NS) Income Statement Analysis – Financial Results
- Shanghai Shuixing Home Textile Co., Ltd. (603365.SS) Income Statement Analysis – Financial Results
- Greenfern Industries Limited (GFI.NZ) Income Statement Analysis – Financial Results
- Century City International Holdings Limited (0355.HK) Income Statement Analysis – Financial Results
- PT Smartfren Telecom Tbk (FREN.JK) Income Statement Analysis – Financial Results
DENTSPLY SIRONA Inc. (XRAY)
About DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.97B | 3.92B | 4.25B | 3.34B | 4.03B | 3.99B | 3.99B | 3.75B | 2.67B | 2.92B | 2.95B | 2.93B | 2.54B | 2.22B | 2.16B | 2.19B | 2.01B | 1.81B | 1.72B | 1.69B | 1.57B | 1.51B | 1.13B | 889.80M | 830.90M | 795.10M | 720.80M | 656.60M | 572.00M | 524.80M | 552.60M | 84.60M | 54.50M | 29.40M | 18.60M | 16.20M | 12.70M | 10.30M |
| Cost of Revenue | 1.88B | 1.80B | 1.89B | 1.69B | 1.86B | 1.92B | 1.80B | 1.74B | 1.16B | 1.32B | 1.37B | 1.37B | 1.26B | 1.09B | 1.05B | 1.04B | 969.05M | 881.49M | 846.12M | 847.71M | 797.72M | 780.84M | 559.42M | 384.84M | 359.30M | 341.20M | 319.60M | 303.80M | 269.70M | 247.00M | 274.00M | 52.30M | 33.70M | 18.00M | 11.50M | 9.90M | 8.00M | 7.00M |
| Gross Profit | 2.09B | 2.13B | 2.36B | 1.66B | 2.17B | 2.07B | 2.19B | 2.00B | 1.52B | 1.60B | 1.58B | 1.56B | 1.27B | 1.13B | 1.11B | 1.15B | 1.04B | 929.01M | 869.02M | 846.52M | 773.20M | 732.90M | 569.67M | 504.95M | 471.60M | 453.90M | 401.20M | 352.80M | 302.30M | 277.80M | 278.60M | 32.30M | 20.80M | 11.40M | 7.10M | 6.30M | 4.70M | 3.30M |
| Gross Profit Ratio | 52.61% | 54.23% | 55.54% | 49.58% | 53.74% | 51.87% | 54.80% | 53.42% | 56.73% | 54.74% | 53.46% | 53.15% | 50.18% | 50.88% | 51.45% | 52.51% | 51.78% | 51.31% | 50.67% | 49.96% | 49.22% | 48.42% | 50.45% | 56.75% | 56.76% | 57.09% | 55.66% | 53.73% | 52.85% | 52.93% | 50.42% | 38.18% | 38.17% | 38.78% | 38.17% | 38.89% | 37.01% | 32.04% |
| Research & Development | 184.00M | 174.00M | 171.00M | 115.00M | 131.30M | 160.50M | 151.70M | 128.50M | 74.90M | 80.80M | 85.10M | 85.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.62B | 1.60B | 1.55B | 0.00 | 0.00 | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | -7.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.62B | 1.59B | 1.55B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 160.30M | 180.00M | 16.70M | 10.50M | 5.50M | 3.90M | 3.40M | 2.90M | 2.30M |
| Other Expenses | 374.00M | 1.29B | 18.00M | 271.00M | 115.00M | 1.34B | 2.07B | 44.10M | 81.20M | 11.10M | 13.40M | -490.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.43M | 0.00 | 0.00 | 0.00 | 0.00 | 5.07M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 4.20M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K |
| Operating Expenses | 2.18B | 1.76B | 1.72B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 680.54M | 602.98M | 563.34M | 544.26M | 501.52M | 479.13M | 391.31M | 341.09M | 322.00M | 312.60M | 268.70M | 233.30M | 201.60M | 180.30M | 199.80M | 19.70M | 12.90M | 6.70M | 4.40M | 3.90M | 3.30M | 2.70M |
| Cost & Expenses | 4.05B | 3.56B | 3.61B | 3.12B | 3.59B | 3.64B | 3.48B | 3.27B | 2.23B | 2.47B | 2.52B | 2.52B | 2.20B | 1.83B | 1.77B | 1.78B | 1.65B | 1.48B | 1.41B | 1.39B | 1.30B | 1.26B | 950.73M | 725.94M | 681.30M | 653.80M | 588.30M | 537.10M | 471.30M | 427.30M | 473.80M | 72.00M | 46.60M | 24.70M | 15.90M | 13.80M | 11.30M | 9.70M |
| Interest Income | 0.00 | 60.00M | 55.00M | 1.00M | 2.40M | 2.10M | 2.40M | 2.00M | 2.20M | 5.59M | 8.12M | 8.76M | 9.46M | 4.25M | 5.03M | 17.09M | 26.43M | 12.48M | 9.01M | 5.47M | 1.87M | 0.00 | 0.00 | 862.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 81.00M | 60.00M | 55.00M | 48.00M | 29.40M | 37.30M | 38.30M | 35.90M | 55.90M | 46.91M | 49.63M | 56.85M | 44.62M | 25.09M | 17.83M | 32.53M | 11.98M | 10.80M | 17.77M | 25.10M | 26.08M | 38.18M | 0.00 | 10.15M | 8.50M | 157.10M | 8.10M | 6.00M | 12.20M | 0.00 | 39.20M | 3.80M | 2.80M | 800.00K | 0.00 | 200.00K | 400.00K | 400.00K |
| Depreciation & Amortization | 343.00M | 328.00M | 346.00M | 334.00M | 322.80M | 330.80M | 316.40M | 271.70M | 122.90M | 129.08M | 127.90M | 129.20M | 85.04M | 66.34M | 65.18M | 56.93M | 50.29M | 47.43M | 50.56M | 49.30M | 45.66M | 43.86M | 54.33M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K | 400.00K |
| EBITDA | 232.00M | -677.00M | 972.00M | 336.00M | 706.60M | -585.30M | -1.25B | 770.50M | 579.30M | 575.25M | 544.88M | 513.34M | 378.71M | 440.00M | 437.28M | 444.33M | 432.26M | 373.21M | 139.00M | 348.77M | 317.34M | 297.63M | 232.70M | 205.22M | 189.20M | 178.70M | 164.90M | 147.60M | 122.20M | 117.50M | 98.60M | 31.60M | 15.60M | 10.30M | 5.90M | 3.20M | 2.90M | 1.80M |
| EBITDA Ratio | 5.85% | 16.17% | 23.57% | 23.64% | 20.97% | 49.83% | 65.43% | 20.63% | 18.87% | 16.01% | 15.11% | 14.80% | 13.26% | 18.11% | 17.97% | 22.19% | 20.92% | 21.14% | 33.94% | 21.25% | 19.96% | 20.02% | 18.64% | 23.38% | 22.41% | 31.40% | 22.56% | 22.08% | 21.64% | 21.95% | 18.24% | 18.79% | 18.72% | 20.07% | 16.67% | 17.90% | 14.17% | 9.71% |
| Operating Income | -85.00M | 306.00M | 622.00M | 456.00M | 522.30M | -958.10M | -1.59B | 454.70M | 375.20M | 445.60M | 419.17M | 381.94M | 300.73M | 380.27M | 381.19M | 380.42M | 354.89M | 314.79M | 72.92M | 295.13M | 267.98M | 256.50M | 178.36M | 163.86M | 149.60M | 141.30M | 132.50M | 119.50M | 100.70M | 97.50M | 78.80M | 12.60M | 7.90M | 4.70M | 2.70M | 2.40M | 1.40M | 600.00K |
| Operating Income Ratio | -2.14% | 7.80% | 14.63% | 13.64% | 12.96% | -24.03% | -39.70% | 12.14% | 14.03% | 15.25% | 14.21% | 13.04% | 11.85% | 17.12% | 17.65% | 17.34% | 17.66% | 17.39% | 4.25% | 17.42% | 17.06% | 16.94% | 15.80% | 18.42% | 18.00% | 17.77% | 18.38% | 18.20% | 17.60% | 18.58% | 14.26% | 14.89% | 14.50% | 15.99% | 14.52% | 14.81% | 11.02% | 5.83% |
| Total Other Income/Expenses | -90.00M | -118.00M | -63.00M | -57.00M | -7.60M | -400.00K | -41.20M | -13.80M | -45.50M | -41.23M | -49.87M | -51.26M | -44.62M | -22.62M | -17.83M | -24.95M | 3.24M | 43.00K | -234.64M | -20.98M | -16.79M | -35.52M | 6.76M | -12.06M | -11.50M | -86.10M | -10.40M | -8.60M | -10.60M | -5.90M | -23.00M | -2.30M | -3.50M | -2.90M | -800.00K | 300.00K | -200.00K | -300.00K |
| Income Before Tax | -175.00M | -1.06B | 559.00M | -60.00M | 345.40M | -958.40M | -1.63B | 440.90M | 329.70M | 404.37M | 369.34M | 330.68M | 256.11M | 357.66M | 363.36M | 355.47M | 358.14M | 314.84M | 71.04M | 274.16M | 251.20M | 220.99M | 185.13M | 151.80M | 138.10M | 55.10M | 122.10M | 110.90M | 90.10M | 91.60M | 55.80M | 9.10M | 5.00M | 3.90M | 2.70M | 2.20M | 1.10M | 0.00 |
| Income Before Tax Ratio | -4.41% | -26.90% | 13.15% | -1.80% | 8.57% | -24.04% | -40.73% | 11.77% | 12.33% | 13.84% | 12.52% | 11.29% | 10.09% | 16.10% | 16.82% | 16.20% | 17.82% | 17.39% | 4.14% | 16.18% | 15.99% | 14.60% | 16.40% | 17.06% | 16.62% | 6.93% | 16.94% | 16.89% | 15.75% | 17.45% | 10.10% | 10.76% | 9.17% | 13.27% | 14.52% | 13.58% | 8.66% | 0.00% |
| Income Tax Expense | -43.00M | -105.00M | 138.00M | 23.00M | 82.30M | 52.50M | -53.20M | 9.50M | 77.00M | 81.12M | 52.15M | 8.92M | -11.02M | 89.23M | 88.94M | 71.60M | 98.48M | 91.12M | 25.63M | 63.87M | 81.34M | 73.03M | 63.63M | 50.78M | 48.20M | 20.30M | 47.50M | 43.70M | 36.10M | 37.50M | 27.70M | 3.80M | 2.10M | 1.50M | 1.00M | 900.00K | 300.00K | 500.00K |
| Net Income | -132.00M | -950.00M | 411.00M | -83.00M | 262.90M | -1.01B | -1.57B | 429.90M | 251.20M | 322.85M | 313.19M | 314.21M | 244.52M | 265.71M | 274.26M | 283.87M | 259.65M | 223.72M | 45.41M | 253.17M | 174.18M | 147.95M | 121.50M | 101.02M | 89.90M | 34.80M | 74.60M | 67.20M | 54.00M | 62.00M | 14.10M | 5.30M | 2.90M | 2.40M | 1.70M | 1.30M | 800.00K | 100.00K |
| Net Income Ratio | -3.33% | -24.22% | 9.67% | -2.48% | 6.52% | -25.36% | -39.39% | 11.48% | 9.39% | 11.05% | 10.61% | 10.73% | 9.64% | 11.96% | 12.70% | 12.94% | 12.92% | 12.36% | 2.65% | 14.94% | 11.09% | 9.77% | 10.76% | 11.35% | 10.82% | 4.38% | 10.35% | 10.23% | 9.44% | 11.81% | 2.55% | 6.26% | 5.32% | 8.16% | 9.14% | 8.02% | 6.30% | 0.97% |
| EPS | -0.62 | -4.41 | 1.88 | -0.38 | 1.18 | -4.51 | -6.86 | 1.97 | 1.79 | 2.28 | 2.20 | 2.22 | 1.73 | 1.85 | 1.85 | 1.90 | 1.71 | 1.44 | 0.29 | 1.58 | 1.11 | 0.95 | 0.78 | 0.65 | 0.57 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| EPS Diluted | -0.62 | -4.41 | 1.87 | -0.38 | 1.17 | -4.51 | -6.86 | 1.94 | 1.76 | 2.24 | 2.16 | 2.18 | 1.70 | 1.82 | 1.83 | 1.87 | 1.68 | 1.41 | 0.28 | 1.55 | 1.09 | 0.93 | 0.77 | 0.65 | 0.56 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| Weighted Avg Shares Out | 212.00M | 215.50M | 218.40M | 219.20M | 223.10M | 224.17M | 229.29M | 218.00M | 140.00M | 141.70M | 142.70M | 141.85M | 141.39M | 143.98M | 148.32M | 149.07M | 151.71M | 155.23M | 159.19M | 160.77M | 157.65M | 156.36M | 155.34M | 155.57M | 158.26M | 159.99M | 161.81M | 161.52M | 162.07M | 165.99M | 151.00M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
| Weighted Avg Shares Out (Dil) | 212.00M | 215.50M | 220.20M | 219.20M | 224.40M | 224.30M | 229.40M | 221.60M | 142.50M | 144.20M | 145.00M | 143.95M | 143.55M | 145.99M | 150.10M | 151.68M | 154.72M | 158.27M | 162.02M | 164.03M | 161.29M | 159.99M | 157.95M | 157.12M | 158.73M | 160.79M | 162.69M | 161.52M | 162.19M | 165.99M | 156.59M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
XRAY Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Investors with Significant Losses to Contact the Firm
RADNOR, PA / ACCESSWIRE / November 19, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) ("DENTSPLY")....
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY
NEW YORK , Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ: XRAY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
XRAY Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Investors with Significant Losses to Contact the Firm
RADNOR, PA / ACCESSWIRE / November 18, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) ("DENTSPLY")....
NASDAQ: XRAY Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Investors with Significant Losses to Contact the Firm
RADNOR, Pa., Nov. 17, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) (“DENTSPLY”).
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY
NEW YORK, NY / ACCESSWIRE / November 16, 2024 / Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY). Such investors are advised to contact Danielle Peyton at [email protected] or...
NASDAQ: XRAY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Investors with Significant Losses to Contact the Firm
RADNOR, Pa. , Nov. 16, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) ("DENTSPLY").
NASDAQ: XRAY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Investors with Significant Losses to Contact the Firm
RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) (“DENTSPLY”). On October 24, 2024, DENTSPLY...
Bronstein, Gewirtz & Grossman, LLC Encourages DENTSPLY SIRONA Inc. (XRAY) Shareholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESSWIRE / November 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY
NEW YORK CITY, NY / ACCESSWIRE / November 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY). Such investors are advised to contact Danielle Peyton at [email protected]...
Bronstein, Gewirtz & Grossman, LLC Is Investigating DENTSPLY SIRONA Inc. (XRAY) And Encourages Shareholders to Connect
NEW YORK CITY, NY / ACCESSWIRE / November 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities...
Source: https://incomestatements.info
Category: Stock Reports